Literature DB >> 18160106

Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant.

Peter Zanvit1, Martina Havlícková, Jaroslav Tácner, Olga Novotná, Marie Jirkovská, Dana Cechová, Jaroslav Julák, Ivan Sterzl, Ludmila Prokesová.   

Abstract

Mucosal immunization by inactivated viruses often fails to evoke a sufficient immune response. Intensive efforts have been made to enhance the response by suitable adjuvants. We used the G+ nonpathogenic delipidated bacterium Bacillus firmus with pronounced immunostimulatory properties as an adjuvant for immunizing mice with inactivated influenza virus type A. BALB/c mice were immunized intratracheally with inactivated influenza A H1N1 and H3N2 viruses. The production of antibodies in sera and secretions was determined by the ELISA. The local situation in the lungs was assessed histologically and by testing the cytokine expression. The protective and cross-protective effect against infection was tested in in vivo experiments after infection with influenza virus A H1N1. B. firmus as adjuvant increased both systemic and mucosal antibody responses, improved protection against homologous virus and induced cross-protection against virus H1N1 after immunization with virus H3N2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160106     DOI: 10.1016/j.imlet.2007.11.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  5 in total

1.  Stimulation of protective and cross-protective immunity against influenza B virus after adjuvant mucosal immunization of mice.

Authors:  L Prokesová; P Zanvit; M Havlícková; J Tácner; M Jirkovská; P Petrásková; O Novotná; D Cechová; J Julák
Journal:  Folia Microbiol (Praha)       Date:  2010-02-07       Impact factor: 2.099

2.  Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus.

Authors:  Dana Cechova; Michaela Novakova; Karel Mikulik; Olga Novotna; Jaroslav Julak; Peter Zanvit; Ludmila Prokesova
Journal:  Folia Microbiol (Praha)       Date:  2012-08-09       Impact factor: 2.099

3.  Intranasal immunization with recombinant HA and mast cell activator C48/80 elicits protective immunity against 2009 pandemic H1N1 influenza in mice.

Authors:  Shu Meng; Zhonghua Liu; Lili Xu; Li Li; Shan Mei; Linlin Bao; Wei Deng; Lina Li; Rongyue Lei; Liangzhi Xie; Chuan Qin; Linqi Zhang
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

4.  Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.

Authors:  Li Pan; Zhongwang Zhang; Jianliang Lv; Peng Zhou; Wenfa Hu; Yuzhen Fang; Haotai Chen; Xinsheng Liu; Junjun Shao; Furong Zhao; Yaozhong Ding; Tong Lin; Huiyun Chang; Jie Zhang; Yongguang Zhang; Yonglu Wang
Journal:  Int J Nanomedicine       Date:  2014-12-02

5.  Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of influenza A virus.

Authors:  Ilya Dukhovlinov; Ruslan Al-Shekhadat; Ekaterina Fedorova; Ludmila Stepanova; Marina Potapchuk; Irina Repko; Olga Rusova; Anton Orlov; Ludmila Tsybalova; Oleg Kiselev
Journal:  Med Sci Monit Basic Res       Date:  2013-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.